Commentary: Preclinical Efficacy of Immune-Checkpoint Monotherapy Does Not Recapitulate Corresponding Biomarkers-Based Clinical Predictions in Glioblastoma by Garg Et Al. (2017)

OncoImmunology - United States
doi 10.1080/2162402x.2018.1548242
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Systemic Immunological Biomarkers of Clinical Responses in Immune Checkpoint Blockade Therapies

Lung Cancer Management
2018English

Commentary on White Et Al . (2017): Adolescent Drinking and Exposure to Advertising-Behaviour Does Not Occur in a Social Vacuum

Addiction
MedicinePsychiatryMental Health
2017English

Prospects of Immune Checkpoint Modulators in the Treatment of Glioblastoma

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2015English

Commentary on Daubresse Et Al. (2017): An Epidemic of Outdated Data

Addiction
MedicinePsychiatryMental Health
2017English

Response to Commentary by Gutierrez Et Al.

Proceedings of the Royal Society B: Biological Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2014English

Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

Cancer Cell
Cancer ResearchOncologyCell Biology
2017English

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Cancer immunology research
Cancer ResearchImmunology
2015English

Commentary on Laude Et Al. (2017): Extended Treatment for Cigarette Smoking Cessation

Addiction
MedicinePsychiatryMental Health
2017English

Global Drivers of Fine Root Trait Variation: Commentary on Freschet Et Al . (2017)

Journal of Ecology
Plant ScienceEvolutionEcologySystematicsBehavior
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy